Affordable Access

A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.

Authors
  • Kramer, M S
  • Matzura-Wolfe, D
  • Polis, A
  • Getson, A
  • Amaraneni, P G
  • Solbach, M P
  • McHugh, W
  • Feighner, J
  • Silberstein, S
  • Reines, S A
Type
Published Article
Journal
Neurology
Publication Date
Sep 01, 1998
Volume
51
Issue
3
Pages
773–781
Identifiers
PMID: 9748025
Source
Medline
License
Unknown

Abstract

Rizatriptan 10 mg PO is efficacious and generally well tolerated in acute migraine. Its efficacy is maintained throughout the treatment of multiple, discrete migraine attacks.

Report this publication

Statistics

Seen <100 times